$72.63
-0.61-0.83%
Last update: 3:23 PM
15 minutes delayed
Comments
Loading...
Haemonetics (NYSE:HAE) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Haemonetics (HAE)?
The most recent guidance for Haemonetics (HAE) was reported on August 8, 2024 for the full year 2025. The company provided earnings per share guidance in the range of $4.45 to $4.75, compared to the estimated EPS of $4.60. Additionally, Haemonetics forecasted revenue between $1.38B and $1.41B for the quarter.
Browse guidance and forecast on all stocks.